Management of Patients with Lower-Risk Myelodysplastic Neoplasms (MDS)

Myelodysplastic neoplasms (MDS) are a heterogenous group of clonal hematologic disorders characterized by morphologic dysplasia, ineffective hematopoiesis, and cytopenia. In the past year, the classification of MDS has been updated in the 5th edition of the World Health Organization (WHO) Classifica...

Descripción completa

Detalles Bibliográficos
Autores principales: Lucero, Josephine, Al-Harbi, Salman, Yee, Karen W. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377892/
https://www.ncbi.nlm.nih.gov/pubmed/37504319
http://dx.doi.org/10.3390/curroncol30070459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377892/
https://www.ncbi.nlm.nih.gov/pubmed/37504319
http://dx.doi.org/10.3390/curroncol30070459

Ejemplares similares